MicroRNA and cutaneous melanoma: from discovery to prognosis and therapy.
about
New target genes of MITF-induced microRNA-211 contribute to melanoma cell invasionHigh intensity focused ultrasound inhibits melanoma cell migration and metastasis through attenuating microRNA-21-mediated PTEN suppression.MicroRNAs induced in melanoma treated with combination targeted therapy of Temsirolimus and BevacizumabmiR-524-5p suppresses the growth of oncogenic BRAF melanoma by targeting BRAF and ERK2.Cholesterol-conjugated let-7a mimics: antitumor efficacy on hepatocellular carcinoma in vitro and in a preclinical orthotopic xenograft model of systemic therapyMicroRNA-143 targets Syndecan-1 to repress cell growth in melanomaDecreased serum microRNA-206 level predicts unfavorable prognosis in patients with melanoma.Extremely Low-Frequency Electromagnetic Fields Affect the miRNA-Mediated Regulation of Signaling Pathways in the GC-2 Cell Line.The Response of microRNAs to Solar UVR in Skin-Resident Melanocytes Differs between Melanoma Patients and Healthy Persons.miR-33a functions as a tumor suppressor in melanoma by targeting HIF-1α.A miRNA-Based Signature Detected in Primary Melanoma Tissue Predicts Development of Brain Metastasis.In vivo Modeling and Molecular Characterization: A Path Toward Targeted Therapy of Melanoma Brain MetastasisIdentification and characterization of microRNAs in Baylisascaris schroederi of the giant pandamiR-579-3p controls melanoma progression and resistance to target therapy.Hypoxia-regulated gene expression explains differences between melanoma cell line-derived xenografts and patient-derived xenografts.CDK/CCN and CDKI alterations for cancer prognosis and therapeutic predictivity.miR-204-5p acts as a tumor suppressor by targeting matrix metalloproteinases-9 and B-cell lymphoma-2 in malignant melanoma.Aberrations in the micro-RNA biogenesis machinery and the emerging roles of micro-RNAs in the pathogenesis of cutaneous malignant melanoma.MicroRNAs in skin response to UV radiation.The role of the dysfunctional akt-related pathway in cancer: establishment and maintenance of a malignant cell phenotype, resistance to therapy, and future strategies for drug development.miRNAs in melanoma: a defined role in tumor progression and metastasis.Prognostic and predictive biomarkers in melanoma: an update.Pivotal MicroRNAs in Melanoma: A Mini-Review.Genetic 3'UTR variation is associated with human pigmentation characteristics and sensitivity to sunlight.MicroRNAs role as potential biomarkers and key regulators in melanoma.microRNA-449a functions as a tumor-suppressor in gastric adenocarcinoma by targeting Bcl-2.Determination of prognosis in metastatic melanoma through integration of clinico-pathologic, mutation, mRNA, microRNA, and protein information.Upregulation of MicroRNA-1246 Is Associated with BRAF Inhibitor Resistance in Melanoma Cells with Mutant BRAF.MicroRNA-Directed Cancer Therapies: Implications in Melanoma Intervention.MicroRNA and mRNA expression profiling in metastatic melanoma reveal associations with BRAF mutation and patient prognosis.
P2860
Q28536746-E31B89D7-662A-42D9-89AE-9CFB112C4D2BQ30365568-3514BACE-F8A6-4FBF-982F-BC3528C45BDEQ30415894-D9D8192A-185E-4F8D-B412-A2B278995510Q34619395-E85E8CE2-C087-49F5-BA83-AC658F162585Q34896601-46D22A93-22B8-4817-BD29-042504BF45C4Q35145657-686CC367-D743-45B8-A689-305C4E6013E6Q35632305-D28B0586-D76C-4E05-BD20-3080D6B252F5Q35800494-F5AA2647-60B1-416E-A5AC-FFBD3F1F064DQ36009638-E2716A90-2360-4157-801D-88484C4C0DEFQ36212884-5292F650-E04D-49BB-ADE3-F2E6D6DFC48BQ36244744-9FBBBE2E-3582-422D-8840-CD2CD5FE1D17Q36889788-1B67999D-20B8-4919-BE0F-7D034E58218BQ37053357-59ADED29-3B5A-4F41-86D9-EDBD8C862FECQ37213837-32C6EF92-6CC3-47C8-AB21-B8829BA6B802Q37269137-FB0425E4-44CD-4006-AFBA-FE5AB6EC5BF2Q37586623-A68AC8F8-3A8E-4384-99EA-492A9FBB1C2BQ37682826-BCA2B419-15A1-4EE0-9FC8-4C02061EABC1Q38041704-AEAB6B26-57AD-4DB4-A2A1-E093E4619FD3Q38119989-6B50C6F0-49B2-4B94-B0A4-33AF05925C6DQ38175044-F59C76C9-4DB1-43E3-ACC8-BCE007007DE6Q38617229-4082096C-312B-4A19-8ACB-FC20DB56809EQ38653619-95D16C32-600D-460A-8110-545743788639Q38879511-E17D8E5F-74DC-4EA0-9479-A5E351DCA6D3Q38925411-E89C38A4-EBC9-4CEC-A718-464F3045E311Q38937088-EB86756B-6952-4B43-839C-D9CB906D2D4EQ42877563-A9CF1C46-040B-4E6B-843A-37FF5816F849Q44133547-D2781311-2132-4175-93A9-F1CD5F41982FQ50019429-A792E878-C953-4359-84D1-10C2E4D37C9EQ50062795-2D6FDC2C-0B21-487B-823F-C277964563CCQ55069393-B4A52AF3-61CB-40C4-8B94-F5C1DE4B09A2
P2860
MicroRNA and cutaneous melanoma: from discovery to prognosis and therapy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
MicroRNA and cutaneous melanoma: from discovery to prognosis and therapy.
@en
type
label
MicroRNA and cutaneous melanoma: from discovery to prognosis and therapy.
@en
prefLabel
MicroRNA and cutaneous melanoma: from discovery to prognosis and therapy.
@en
P2093
P2860
P356
P1433
P1476
MicroRNA and cutaneous melanoma: from discovery to prognosis and therapy.
@en
P2093
Doug Hanniford
Eva Hernando
Holly S Greenwald
Iman Osman
Miguel F Segura
P2860
P304
P356
10.1093/CARCIN/BGS205
P407
P577
2012-06-12T00:00:00Z